In IBD, adaptive immunity is mainly led by CD4+ and CD8+ T cells, and regulatory T cells (Treg), and the active participation of the different populations of cells accounts for heterogeneous effects and disease manifestation in IBD patients [85]. The gene discussed is CD4; the disease is irritable bowel syndrome.